Brainstorm Cell Therapeutics Inc. (BCLI)

NASDAQ: BCLI · Real-Time Price · USD

0.9900

+0.0700 (7.61%)

At close: Apr 25, 2025, 4:00 PM

0.9801

-0.0099 (-1.00%)

After-hours: Apr 25, 2025, 4:23 PM EDT

BCLI Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Net Income	-11.62	-17.19	-24.28	-24.46	-31.81	Upgrade
Depreciation & Amortization	0.24	0.27	0.29	0.26	0.22	Upgrade
Stock-Based Compensation	0.75	1.49	1.68	1.37	2.56	Upgrade
Change in Accounts Receivable	0.4	-0.48	1.07	0.34	1.49	Upgrade
Change in Accounts Payable	1.13	-1.27	2.52	-1.72	-9.26	Upgrade
Change in Other Net Operating Assets	0.01	-3.28	-0.6	-2.05	1.61	Upgrade
Operating Cash Flow	-9.09	-20.46	-19.32	-26.27	-35.19	Upgrade
Capital Expenditures	-	-0.02	-0.03	-0.33	-0.38	Upgrade
Sale of Property, Plant & Equipment	0.01	-	-	-	-	Upgrade
Investment in Securities	-	2.21	1.03	0.65	-4.07	Upgrade
Investing Cash Flow	0.01	2.19	1	0.32	-4.45	Upgrade
Issuance of Common Stock	7.97	18.98	0.24	6.97	77.05	Upgrade
Repurchase of Common Stock	-	-	-	-	-0.12	Upgrade
Financing Cash Flow	7.97	18.98	0.24	6.97	76.94	Upgrade
Net Cash Flow	-1.11	0.71	-18.08	-18.97	37.29	Upgrade
Free Cash Flow	-9.09	-20.48	-19.35	-26.6	-35.57	Upgrade
Free Cash Flow Per Share	-1.81	-7.13	-7.95	-11.03	-17.88	Upgrade
Levered Free Cash Flow	-5.03	-12.49	-10	-17.64	-23.81	Upgrade
Unlevered Free Cash Flow	-4.99	-12.31	-10	-17.64	-23.73	Upgrade
Change in Net Working Capital	-1.33	0.65	-3.58	3.6	6.33	Upgrade

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q